Minerva Neurosciences, Inc. (NERV)

4.01 -0.01 (-0.25%) USD  |  NASDAQ  |  Jan 02, 16:00
4.18 +0.17 (+4.24%) After-Hours: 20:00
More

Minerva Neurosciences Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for NERV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
iBio, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. --
Theriva Biologics, Inc. Upgrade
Oragenics, Inc. Upgrade